CIP
NXTM

Chartwell Investment Partners’s NxStage Medical Inc. NXTM Stock Holding History

Chartwell Investment Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-101,188
Closed -$2.54M – 452
2017
Q2 		$2.54M Buy
101,188
+38
+0% +$941 0.1% 260
2017
Q1 		$2.71M Sell
101,150
-47,745
-32% -$1.32M 0.1% 242
2016
Q4 		$3.9M Sell
148,895
-257,110
-63% -$6.36M 0.13% 223
2016
Q3 		$10.1M Buy
406,005
+90,485
+29% +$2.11M 0.18% 176
2016
Q2 		$6.84M Buy
315,520
+60,040
+24% +$1.07M 0.12% 200
2016
Q1 		$3.83M Sell
255,480
-315,150
-55% -$5.28M 0.07% 230
2015
Q4 		$12.5M Sell
570,630
-112,890
-17% -$2.1M 0.26% 116
2015
Q3 		$10.8M Sell
683,520
-1,162,134
-63% -$18.6M 0.23% 143
2015
Q2 		$26.4M Sell
1,845,654
-256,485
-12% -$4.34M 0.51% 54
2015
Q1 		$36.4M Buy
2,102,139
+1,738,319
+478% +$30.7M 0.71% 35
2014
Q4 		$6.52M Buy
+363,820
New +$5.86M 0.14% 245

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Chartwell Investment Partners's NXTM Position: Q3 2017 in Review

Chartwell Investment Partners sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 101,188 shares — an estimated $2.54M sold.

Chartwell Investment Partners first reported a position in NXTM in Q4 2014 and held it in 11 quarters. The position peaked at $36.4M in Q1 2015. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Chartwell Investment Partners reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Chartwell Investment Partners sold 101,188 NxStage Medical Inc. shares in Q3 2017, an estimated $2.54M.
  • Chartwell Investment Partners first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 11 quarters.
  • Chartwell Investment Partners's NxStage Medical Inc. position peaked at $36.4M in Q1 2015.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Chartwell Investment Partners's 13F filing for Q3 2017, filed 8 Nov 2017.